All posts by: Michael Zand

About Michael Zand

Researchers: Synthetic stem cells could offer therapeutic benefits, reduced risks – WRAL Tech Wire

Continue reading

2017-01-10 NEWS

Researchers: Synthetic stem cells could offer therapeutic benefits, reduced risks
WRAL Tech Wire
Raleigh, N.C. — Researchers from North Carolina State University, the University of North Carolina at Chapel Hill and First Affiliated Hospital of Zhengzhou University have developed a synthetic version of a cardiac stem cell. These synthetic stem

Continue reading

2017-01-10 NEWS

MarketWatch

Stem Cell Research Provides New Hope for Heart Patients
MarketWatch
Not for a transplanted heart, but for regaining some of their own heart’s functionality. Cardiologist Dr. Joshua Hare joins Lunch Break With Tanya Rivero to discuss advancements in stem cell research to treat cardiac patients. Photo: iStock This video

and more »

Continue reading

2017-01-10 NEWS

GoLocalProv

DMX in Brawl with RI Vet Over Months of Unpaid Pit Bull Bills
GoLocalProv
“So I reach out to him on November 27 on my cell phone, not the business phone, and he picked up,” said Callahan. “We had a long discussion — I said you can’t keep animals in suspended animation with no end date. I said you owe us this [amount], it’s

Continue reading

2017-01-10 NEWS

Boston Business Journal

Sarepta eyes a different approach to Duchenne: gene therapy
Boston Business Journal
Sarepta (Nasdaq: SRPT) announced Tuesday that it had reached an agreement with Ohio-based Nationwide Children’s Hospital to exclusively license a pre-clinical program that seeks to treat DMD through gene therapy. The company also said it had entered …
Sarepta Therapeutics (SRPT) Licenses Galgt2 Gene Therapy Program from Nationwide Children’s HospitalStreetInsider.com
Sarepta Enters the Gene Therapy BusinessRare Disease Report
For Sarepta, Today’s Good News Might Be Just The BeginningBenzinga

all 63 news articles »

Continue reading

2017-01-10 NEWS

CTV News

Ont. government approves funding for ‘Butterfly Boy’ Johnathan Pitre’s 2nd stem cell transplant
CTV News
Some good news for the family of Jonathan Pitre. The Ontario government has approved funding for a second stem cell transplant for the local teenager. The 16-year-old from Russell, Ont. suffers from a blistering skin disease.